NASDAQ:SBPH
Delisted
Spring Bank Pharmaceuticals Stock News
$10.80
+1.74 (+19.21%)
At Close: Feb 03, 2021
CORRECTING and REPLACING Spring Bank Pharmaceuticals Stockholders Approve Combination with F-star Therapeutics
12:53pm, Friday, 20'th Nov 2020
HOPKINTON, Mass., Nov. 20, 2020 /PRNewswire/ -- Please replace the release dated November 19, 2020 with the following corrected version due to revisions to the headline. The corrected release reads: H
Spring Bank Pharmaceuticals Stockholders Approve Combination with F-star Therapeutics
05:00pm, Thursday, 19'th Nov 2020
1-for-4 Reverse Stock Split to be Effective November 20, 2020 1-for-4 Reverse Stock Split to be Effective November 20, 2020
Spring Bank Pharmaceuticals Announces Special Dividend of Contingent Value Rights
05:01pm, Friday, 06'th Nov 2020
HOPKINTON, Mass., Nov. 06, 2020 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH) (“Spring Bank”), a clinical-stage biopharmaceutical company developing novel therapeutics for o
Spring Bank Announces Poster Presentation at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting
08:00am, Monday, 02'nd Nov 2020
HOPKINTON, Mass., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for oncology and inflamma
